Results 161 to 164 of about 11,948 (164)

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

New England Journal of Medicine, 2017
Peter C Taylor, Edward C Keystone, Michael E Weinblatt   +2 more
exaly  

Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Annals of the Rheumatic Diseases, 2017
Maxime Dougados, Désirée M Van Der Heijde, Maria Greenwald   +2 more
exaly  

Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis

Arthritis and Rheumatology, 2019
Peter C Taylor, Michael E Weinblatt, Gerd R Burmester   +2 more
exaly  

Baricitinib: A Review in Rheumatoid Arthritis

Drugs, 2018
exaly